Literature DB >> 33159662

Safety and efficacy of robot-assisted versus open pancreaticoduodenectomy: a meta-analysis of multiple worldwide centers.

Wei Zhang1, Zhangkan Huang2, Jianwei Zhang1, Xu Che3,4.   

Abstract

The objective of the study is to compare the safety and efficacy of robot-assisted pancreaticoduodenectomy (PD) with open PD. The PubMed, EMBASE and Cochrane Library databases were searched for the literature available from their respective inception dates up to May 2020 to find studies comparing robot-assisted pancreaticoduodenectomy (RPD) with open pancreaticoduodenectomy (OPD). The RevMan 5.3 statistical software was used for analysis to evaluate surgical outcome and oncology safety. The combination ratio (RR) and weighted mean difference (WMD) and their 95% confidence intervals (CIs) were calculated using fixed-effect or random effect models. 18 cohort studies from 16 medical centers were eligible with a total of 5795 patients including 1420 RPD group patients and 4375 OPD group patients. The RPD group fared better than the OPD group in terms of estimated blood loss (EBL) (WMD = - 175.65, 95% CI (- 251.85, - 99.44), P < 0.00001), wound infection rate (RR = 0.60, 95% CI (0.44, 0.81), P = 0.001), reoperation rate (RR = 0.61, 95% CI (0.41, 0.91), P = 0.02), hospital day (WMD = - 2.95, 95% CI (- 5.33, - 0.56), P = 0.02), intraoperative blood transfusion (RR = 0.56, 95% CI (0.42, 0.76), P = 0.0001), overall complications (RR = 0.78, 95% CI (0.64, 0.95), P = 0.01), and clinical postoperative pancreatic fistula (POPF) (RR = 0.54, 95% CI (0.41, 0.70), P < 0.0001). In terms of lymph node clearance (WMD = 0.48, 95% CI (- 2.05, 3.02), P = 0.71), R0 rate (RR = 1.05, 95% CI (1.00, 1.11), P = 0.05), postoperative pancreatic fistula (RR = 1, 95% CI (0.85, 1.19), P = 0.97), bile leakage (RR = 0.99, 95% CI (0.54, 1.83), P = 0.98), delayed gastric emptying (DGE) (RR = 0.79, 95% CI (0.60, 1.03), P = 0.08), 90-day mortality (RR = 0.82, 95% CI (0.62, 1.10), P = 0.19), and severe complications (RR = 0.98, 95% CI (0.71, 1.36), P = 0.91), and there were no significant differences between the two groups. Robotic surgery was inferior to open surgery in terms of operational time (WMD = 80.85, 95% CI (16.09, 145.61), P = 0.01). RPD is not inferior to OPD, and it is even more advantageous for EBL, wound infection rate, reoperation rate, hospital stay, intraoperative transfusion, overall complications and clinical POPF. However, these findings need to be further verified by high-quality randomized controlled trials.

Entities:  

Keywords:  Complications; Meta-analysis; Open surgery; Pancreaticoduodenectomy; Robotic surgery

Year:  2020        PMID: 33159662     DOI: 10.1007/s13304-020-00912-5

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  2 in total

1.  A pre-operative platelet transfusion algorithm for patients with cirrhosis and hepatocellular carcinoma undergoing laparoscopic microwave ablation.

Authors:  Maria Baimas-George; Michael Watson; Patrick Salibi; Keith J Murphy; Dionisios Vrochides; John B Martinie; Erin H Baker; David A Iannitti
Journal:  Surg Endosc       Date:  2020-07-06       Impact factor: 4.584

2.  Oncologic Outcomes After Robotic Pancreatic Resections Are Not Inferior to Open Surgery.

Authors:  Mark D Girgis; Mazen S Zenati; Jonathan C King; Ahmad Hamad; Amer H Zureikat; Herbert J Zeh; Melissa E Hogg
Journal:  Ann Surg       Date:  2019-10-28       Impact factor: 12.969

  2 in total
  4 in total

1.  Robot-assisted pancreatoduodenectomy with the da Vinci Xi: can the costs of advanced technology be offset by clinical advantages? A case-matched cost analysis versus open approach.

Authors:  Gregorio Di Franco; Valentina Lorenzoni; Matteo Palmeri; Niccolò Furbetta; Simone Guadagni; Desirée Gianardi; Matteo Bianchini; Luca Emanuele Pollina; Franca Melfi; Domenica Mamone; Carlo Milli; Giulio Di Candio; Giuseppe Turchetti; Luca Morelli
Journal:  Surg Endosc       Date:  2021-10-27       Impact factor: 3.453

2.  EUS-guided gallbladder drainage in high-risk surgical patients with acute cholecystitis-procedure outcomes and evaluation of mortality predictors.

Authors:  Andrea Lisotti; Romano Linguerri; Igor Bacchilega; Anna Cominardi; Gianmarco Marocchi; Pietro Fusaroli
Journal:  Surg Endosc       Date:  2021-01-28       Impact factor: 4.584

3.  Nomogram for Predicting the Prognoses of Patients With Pancreatic Head Cancer After Pancreaticoduodenectomy: A Population-Based Study on SEER Data.

Authors:  Wei Zhang; Lin Xu; Xu Che
Journal:  Front Oncol       Date:  2021-11-04       Impact factor: 6.244

4.  Choice of operative method for pancreaticojejunostomy and a multivariable study of pancreatic leakage in pancreaticoduodenectomy.

Authors:  Hui Liang; Jian-Guo Wu; Fei Wang; Bo-Xuan Chen; Shi-Tian Zou; Cong Wang; Shuai-Wu Luo
Journal:  World J Gastrointest Surg       Date:  2021-11-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.